FGC
ABMD

Financial Gravity Companies’s Abiomed Inc ABMD Stock Holding History

Financial Gravity Companies’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		$47K Buy
+135
New +$46.9K 0.04% 355
2018
Q1 		$4K Sell
14
-10
-42% -$2.53K ﹤0.01% 810
2017
Q4 		$6K Buy
+24
New +$4.48K 0.01% 695

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Financial Gravity Companies's ABMD Position: Q4 2018 in Review

Financial Gravity Companies opened a new position in Abiomed Inc (ABMD) in Q4 2018: 135 shares worth $47K. The stake represents 0.04% of the portfolio and ranks #355 among its holdings. This is a return to the name: Financial Gravity Companies previously reported a position in ABMD as recently as Q1 2018.

Financial Gravity Companies first reported a position in ABMD in Q4 2017 and has held it in 3 quarters since. 529 funds tracked by Wall St. Rank hold ABMD as of Q4 2018.

  • Financial Gravity Companies held 135 shares of Abiomed Inc worth $47K as of Q4 2018.
  • Abiomed Inc was a new Financial Gravity Companies position in Q4 2018.
  • Abiomed Inc made up 0.04% of Financial Gravity Companies's portfolio in Q4 2018, its #355 holding.
  • Financial Gravity Companies first reported a position in Abiomed Inc in Q4 2017 and has held it in 3 quarters since.
  • 529 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2018.

Based on Financial Gravity Companies's 13F filing for Q4 2018, filed 4 Feb 2019.